Journal article
A new humanized HLA transgenic mouse model of multiple sclerosis expressing class II on mouse CD4 T cells
Annals of the New York Academy of Sciences, Vol.1103(1), pp.112-117
04/2007
DOI: 10.1196/annals.1394.005
PMCID: PMC2266826
PMID: 17376829
Abstract
Among all the genetic factors associated with susceptibility to multiple sclerosis (MS), the strongest association has been seen with expression of certain major histocompatibility complex (MHC) class II molecules, although analysis of their exact function remains complicated. In general, the expression of class II is restricted to professional antigen-presenting cells; however, human but not mouse CD4+ T cells express class II on their surface. Functional studies of class II+ CD4+ T cells have been hampered due to lack of a proper animal model. Here, we describe development and characterization of a new humanized class II transgenic (tg) mouse expressing HLA-DR3 on mouse endogenous class II-negative background.
Details
- Title: Subtitle
- A new humanized HLA transgenic mouse model of multiple sclerosis expressing class II on mouse CD4 T cells
- Creators
- Ashutosh Mangalam - Department of Immunology, Mayo Clinic College of Medicine, 200 1st Street SW, Rochester, MN 55905, USA. mangalam.ashutosh@mayo.eduMoses RodriguezChella David
- Resource Type
- Journal article
- Publication Details
- Annals of the New York Academy of Sciences, Vol.1103(1), pp.112-117
- DOI
- 10.1196/annals.1394.005
- PMID
- 17376829
- PMCID
- PMC2266826
- NLM abbreviation
- Ann N Y Acad Sci
- ISSN
- 0077-8923
- eISSN
- 1749-6632
- Publisher
- United States
- Grant note
- R01 NS052173 / NINDS NIH HHS R01 NS052173-02 / NINDS NIH HHS
- Language
- English
- Date published
- 04/2007
- Academic Unit
- Pathology; Iowa Neuroscience Institute
- Record Identifier
- 9983905528502771
Metrics
35 Record Views